{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T05:56:44Z","timestamp":1784699804413,"version":"3.55.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T00:00:00Z","timestamp":1623974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T00:00:00Z","timestamp":1623974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100010733","name":"B\u00f8rnecancerfonden","doi-asserted-by":"publisher","award":["2019-5934"],"award-info":[{"award-number":["2019-5934"]}],"id":[{"id":"10.13039\/100010733","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006313","name":"Barncancerfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008363","name":"Kr\u00e6ftens Bek\u00e6mpelse","doi-asserted-by":"publisher","award":["R-257-A14720"],"award-info":[{"award-number":["R-257-A14720"]}],"id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010339","name":"Ingeni\u00f8r Otto Christensens Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005275","name":"Region Hovedstaden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005275","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005111","name":"Rigshospitalet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005111","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s00280-021-04316-z","type":"journal-article","created":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T19:02:26Z","timestamp":1624042946000},"page":"911-917","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Maintenance therapy and risk of osteonecrosis in children and young adults with acute lymphoblastic leukemia: a NOPHO ALL2008 sub-study"],"prefix":"10.1007","volume":"88","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9871-7637","authenticated-orcid":false,"given":"Linea Natalie","family":"Toksvang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3437-8338","authenticated-orcid":false,"given":"Liv","family":"Andr\u00e9s-Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0578-3887","authenticated-orcid":false,"given":"Cecilie Utke","family":"Rank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riitta","family":"Niinim\u00e4ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9144-7972","authenticated-orcid":false,"given":"Jacob","family":"Nersting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stine Nygaard","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Signe Sloth","family":"Mogensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2767-5828","authenticated-orcid":false,"given":"Arja","family":"Harila-Saari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9240-3522","authenticated-orcid":false,"given":"Jonas","family":"Abrahamsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Joelsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrik Malthe","family":"Overgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petter","family":"Quist-Paulsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laimonas","family":"Gri\u0161kevi\u010dius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d3lafur Gisli","family":"J\u00f3nsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goda","family":"Vaitkevi\u010dien\u0117","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8495-5274","authenticated-orcid":false,"given":"Thomas Leth","family":"Frandsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Toft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6398-6979","authenticated-orcid":false,"given":"Kathrine","family":"Grell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0829-4993","authenticated-orcid":false,"given":"Kjeld","family":"Schmiegelow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,18]]},"reference":[{"key":"4316_CR1","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/S1470-2045(12)70274-7","volume":"13","author":"LA Mattano","year":"2012","unstructured":"Mattano LA, Devidas M, Nachman JB et al (2012) Effect of alternate-week versus continuous dexamethasone scheduling on the risk of osteonecrosis in paediatric patients with acute lymphoblastic leukaemia: results from the CCG-1961 randomised cohort trial. Lancet Oncol 13:906\u2013915. https:\/\/doi.org\/10.1016\/S1470-2045(12)70274-7","journal-title":"Lancet Oncol"},{"key":"4316_CR2","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.3324\/haematol.2016.147595","volume":"101","author":"M Kunstreich","year":"2016","unstructured":"Kunstreich M, Kummer S, Laws H-J et al (2016) Osteonecrosis in children with acute lymphoblastic leukemia. Haematologica 101:1295\u20131305. https:\/\/doi.org\/10.3324\/haematol.2016.147595","journal-title":"Haematologica"},{"key":"4316_CR3","doi-asserted-by":"publisher","first-page":"e231","DOI":"10.1016\/S1470-2045(16)30035-3","volume":"17","author":"K Schmiegelow","year":"2016","unstructured":"Schmiegelow K, Attarbaschi A, Barzilai S et al (2016) Consensus definitions of 14 severe acute toxic effects for childhood lymphoblastic leukaemia treatment: a Delphi consensus. Lancet Oncol 17:e231\u2013e239. https:\/\/doi.org\/10.1016\/S1470-2045(16)30035-3","journal-title":"Lancet Oncol"},{"key":"4316_CR4","doi-asserted-by":"publisher","first-page":"e27300","DOI":"10.1002\/pbc.27300","volume":"65","author":"SS Mogensen","year":"2018","unstructured":"Mogensen SS, Harila-Saari A, M\u00e4kitie O et al (2018) Comparing osteonecrosis clinical phenotype, timing, and risk factors in children and young adults treated for acute lymphoblastic leukemia. Pediatr Blood Cancer 65:e27300. https:\/\/doi.org\/10.1002\/pbc.27300","journal-title":"Pediatr Blood Cancer"},{"key":"4316_CR5","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.3324\/haematol.2012.081265","volume":"98","author":"P Girard","year":"2013","unstructured":"Girard P, Auquier P, Barlogis V et al (2013) Symptomatic osteonecrosis in childhood leukemia survivors: prevalence, risk factors and impact on quality of life in adulthood. Haematologica 98:1089\u20131097. https:\/\/doi.org\/10.3324\/haematol.2012.081265","journal-title":"Haematologica"},{"key":"4316_CR6","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/j.1365-2141.2011.08871.x","volume":"155","author":"A Vora","year":"2011","unstructured":"Vora A (2011) Management of osteonecrosis in children and young adults with acute lymphoblastic leukaemia. Br J Haematol 155:549\u2013560. https:\/\/doi.org\/10.1111\/j.1365-2141.2011.08871.x","journal-title":"Br J Haematol"},{"key":"4316_CR7","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1182\/blood-2015-05-643601","volume":"126","author":"SE Karol","year":"2015","unstructured":"Karol SE, Yang W, Van Driest SL et al (2015) Genetics of glucocorticoid-associated osteonecrosis in children with acute lymphoblastic leukemia. Blood 126:1770\u20131776. https:\/\/doi.org\/10.1182\/blood-2015-05-643601","journal-title":"Blood"},{"key":"4316_CR8","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1182\/blood-2010-10-311969","volume":"117","author":"JD Kawedia","year":"2011","unstructured":"Kawedia JD, Kaste SC, Pei D et al (2011) Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia. Blood 117:2340\u20132347. https:\/\/doi.org\/10.1182\/blood-2010-10-311969","journal-title":"Blood"},{"key":"4316_CR9","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.ejca.2006.11.002","volume":"43","author":"A Sala","year":"2007","unstructured":"Sala A, Mattano LA, Barr RD (2007) Osteonecrosis in children and adolescents with cancer\u2014an adverse effect of systemic therapy. Eur J Cancer 43:683\u2013689. https:\/\/doi.org\/10.1016\/j.ejca.2006.11.002","journal-title":"Eur J Cancer"},{"key":"4316_CR10","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1097\/MPH.0000000000000206","volume":"36","author":"K Schmiegelow","year":"2014","unstructured":"Schmiegelow K, Nielsen SN, Frandsen TL, Nersting J (2014) Mercaptopurine\/Methotrexate maintenance therapy of childhood acute lymphoblastic leukemia: clinical facts and fiction. J Pediatr Hematol Oncol 36:503\u2013517. https:\/\/doi.org\/10.1097\/MPH.0000000000000206","journal-title":"J Pediatr Hematol Oncol"},{"key":"4316_CR11","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nrc2292","volume":"8","author":"P Karran","year":"2008","unstructured":"Karran P, Attard N (2008) Thiopurines in current medical practice: molecular mechanisms and contributions to therapy-related cancer. Nat Rev Cancer 8:24\u201336. https:\/\/doi.org\/10.1038\/nrc2292","journal-title":"Nat Rev Cancer"},{"key":"4316_CR12","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s00280-018-3704-7","volume":"83","author":"J Nersting","year":"2019","unstructured":"Nersting J, Nielsen SN, Grell K et al (2019) Methotrexate polyglutamate levels and co-distributions in childhood acute lymphoblastic leukemia maintenance therapy. Cancer Chemother Pharmacol 83:53\u201360. https:\/\/doi.org\/10.1007\/s00280-018-3704-7","journal-title":"Cancer Chemother Pharmacol"},{"key":"4316_CR13","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/MPH.0b013e3181a6e191","volume":"31","author":"BA Kamen","year":"2009","unstructured":"Kamen BA (2009) Serendipity-methotrexate and 6-mercaptopurine for continuation therapy for patients with acute lymphoblastic leukemia: the leukemic stem cell and beyond? J Pediatr Hematol Oncol 31:383\u2013384. https:\/\/doi.org\/10.1097\/MPH.0b013e3181a6e191","journal-title":"J Pediatr Hematol Oncol"},{"key":"4316_CR14","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.ejca.2013.09.027","volume":"50","author":"TL Frandsen","year":"2014","unstructured":"Frandsen TL, Heyman M, Abrahamsson J et al (2014) Complying with the European clinical trials directive while surviving the administrative pressure\u2014an alternative approach to toxicity registration in a cancer trial. Eur J Cancer 50:251\u2013259. https:\/\/doi.org\/10.1016\/j.ejca.2013.09.027","journal-title":"Eur J Cancer"},{"key":"4316_CR15","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1200\/JCO.18.01877","volume":"37","author":"BK Albertsen","year":"2019","unstructured":"Albertsen BK, Grell K, Abrahamsson J et al (2019) Intermittent versus continuous PEG-asparaginase to reduce asparaginase-associated toxicities: a NOPHO ALL2008 randomized study. J Clin Oncol 37:1638\u20131646. https:\/\/doi.org\/10.1200\/JCO.18.01877","journal-title":"J Clin Oncol"},{"key":"4316_CR16","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1007\/s00216-012-6581-7","volume":"405","author":"E den Boer","year":"2013","unstructured":"den Boer E, Meesters RJW, van Zelst BD et al (2013) Measuring methotrexate polyglutamates in red blood cells: a new LC-MS\/MS-based method. Anal Bioanal Chem 405:1673\u20131681. https:\/\/doi.org\/10.1007\/s00216-012-6581-7","journal-title":"Anal Bioanal Chem"},{"key":"4316_CR17","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1373\/clinchem.2003.026096","volume":"50","author":"M Shipkova","year":"2004","unstructured":"Shipkova M, Niedmann PD, Armstrong VW et al (2004) Determination of thiopurine methyltransferase activity in isolated human erythrocytes does not reflect putative in vivo enzyme inhibition by sulfasalazine. Clin Chem 50:438\u2013441. https:\/\/doi.org\/10.1373\/clinchem.2003.026096","journal-title":"Clin Chem"},{"key":"4316_CR18","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jchromb.2011.11.032","volume":"881\u2013882","author":"JH Jacobsen","year":"2012","unstructured":"Jacobsen JH, Schmiegelow K, Nersting J (2012) Liquid chromatography-tandem mass spectrometry quantification of 6-thioguanine in DNA using endogenous guanine as internal standard. J Chromatogr B Analyt Technol Biomed Life Sci 881\u2013882:115\u2013118. https:\/\/doi.org\/10.1016\/j.jchromb.2011.11.032","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"4316_CR19","doi-asserted-by":"publisher","first-page":"e175","DOI":"10.3324\/haematol.2016.160507","volume":"102","author":"SS Mogensen","year":"2017","unstructured":"Mogensen SS, Schmiegelow K, Grell K et al (2017) Hyperlipidemia is a risk factor for osteonecrosis in children and young adults with acute lymphoblastic leukemia. Haematologica 102:e175\u2013e178. https:\/\/doi.org\/10.3324\/haematol.2016.160507","journal-title":"Haematologica"},{"key":"4316_CR20","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1200\/JCO.2014.57.5480","volume":"33","author":"SC Kaste","year":"2015","unstructured":"Kaste SC, Pei D, Cheng C et al (2015) Utility of early screening magnetic resonance imaging for extensive hip osteonecrosis in pediatric patients treated with glucocorticoids. J Clin Oncol 33:610\u2013615. https:\/\/doi.org\/10.1200\/JCO.2014.57.5480","journal-title":"J Clin Oncol"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-021-04316-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00280-021-04316-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-021-04316-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T08:15:05Z","timestamp":1632989705000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00280-021-04316-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,18]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["4316"],"URL":"https:\/\/doi.org\/10.1007\/s00280-021-04316-z","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,18]]},"assertion":[{"value":"30 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All authors approved the final manuscript and gave consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This study is part of the NOPHO ALL2008 maintenance study (Danish Regional Ethical Committee Study Approval: H-2-2010-002) and both oral and written informed consent to participate were provided by patients or legal guardians according to the Helsinki II Declaration and ICH\/GCP guidelines.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}